Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Kathie M. Bishop, PhD
Senior Vice President and Head of Rare Disease and External Innovation
Acadia Pharmaceuticals Inc
Poster(s):
058: Population Pharmacokinetic Modelling to Predict Trofinetide Exposure & Exposure-Response Safety Analyses in Girls With Rett Syndrome Aged 2–4 Years
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
072: Population Pharmacokinetic Modelling to Confirm Weight-Based Banded Dosing & Exposure-Response Efficacy Analyses to Support Trofinetide Treatment in Rett Syndrome
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
132: Limited Potential for Interactions Between Trofinetide, a New Treatment for Rett Syndrome, & Drugs Metabolized By CYP3A4
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
